These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7772199)

  • 1. Protein kinase C activation is not a key step in ADP-mediated exposure of fibrinogen receptors on human platelets.
    Pulcinelli FM; Ashby B; Gazzaniga PP; Daniel JL
    FEBS Lett; 1995 May; 364(1):87-90. PubMed ID: 7772199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.
    Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP
    Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure of platelet fibrinogen receptors by zinc ions: role of protein kinase C.
    Trybulec M; Kowalska MA; McLane MA; Silver L; Lu W; Niewiarowski S
    Proc Soc Exp Biol Med; 1993 May; 203(1):108-16. PubMed ID: 8475131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors.
    Shattil SJ; Haimovich B; Cunningham M; Lipfert L; Parsons JT; Ginsberg MH; Brugge JS
    J Biol Chem; 1994 May; 269(20):14738-45. PubMed ID: 7514181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
    Puri RN; Kumar A; Chen H; Colman RF; Colman RW
    J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant activation of Gi protein-coupled receptor and protein kinase C or phospholipase C is required for platelet aggregation.
    Pulcinelli FM; Ciampa MT; Favilla M; Pignatelli P; Riondino S; Gazzaniga PP
    FEBS Lett; 1999 Oct; 460(1):37-40. PubMed ID: 10571057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cordycepin-enriched WIB801C from Cordyceps militaris inhibits ADP-induced [Ca(2+)] i mobilization and fibrinogen binding via phosphorylation of IP 3R and VASP.
    Lee DH; Kwon HW; Kim HH; Lim DH; Nam GS; Shin JH; Kim YY; Kim JL; Lee JJ; Kwon HK; Park HJ
    Arch Pharm Res; 2015 Jan; 38(1):81-97. PubMed ID: 25001901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for direct coupling of primary agonist-receptor interaction to the exposure of functional IIb-IIIa complexes in human blood platelets. Results from studies with the antiplatelet compound ajoene.
    Apitz-Castro R; Jain MK; Bartoli F; Ledezma E; Ruiz MC; Salas R
    Biochim Biophys Acta; 1991 Sep; 1094(3):269-80. PubMed ID: 1911878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen binding is independent of an increase in intracellular calcium concentration in thrombin degranulated platelets.
    Pulcinelli FM; Daniel JL; Riondino S; Gazzaniga PP; Salganicoff L
    Thromb Haemost; 1995 Feb; 73(2):304-8. PubMed ID: 7792747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc ions potentiate adenosine diphosphate-induced platelet aggregation by activation of protein kinase C.
    Kowalska MA; Juliano D; Trybulec M; Lu W; Niewiarowski S
    J Lab Clin Med; 1994 Jan; 123(1):102-9. PubMed ID: 8288949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
    Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
    Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C.
    Vezza R; Roberti R; Nenci GG; Gresele P
    Blood; 1993 Nov; 82(9):2704-13. PubMed ID: 8219223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
    Lockhart LK; McNicol A
    J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of protein kinase C-independent exocytosis in human platelets.
    Hashimoto Y; Togo M; Sato H; Hashimoto N; Watanabe T; Kurokawa K; Nakahara K
    Thromb Res; 1997 Oct; 88(1):51-8. PubMed ID: 9336873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation.
    Roger S; Pawlowski M; Habib A; Jandrot-Perrus M; Rosa JP; Bryckaert M
    FEBS Lett; 2004 Jan; 556(1-3):227-35. PubMed ID: 14706855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein VI-mediated platelet fibrinogen receptor activation occurs through calcium-sensitive and PKC-sensitive pathways without a requirement for secreted ADP.
    Quinton TM; Ozdener F; Dangelmaier C; Daniel JL; Kunapuli SP
    Blood; 2002 May; 99(9):3228-34. PubMed ID: 11964287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
    Martinson EA; Scheible S; Marx-Grunwitz A; Presek P
    Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
    Packham MA; Livne AA; Ruben DH; Rand ML
    Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LDL oxidized by hypochlorous acid causes irreversible platelet aggregation when combined with low levels of ADP, thrombin, epinephrine, or macrophage-derived chemokine (CCL22).
    Coleman LG; Polanowska-Grabowska RK; Marcinkiewicz M; Gear AR
    Blood; 2004 Jul; 104(2):380-9. PubMed ID: 15054038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.